45 participants
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-03-28
- Start Date:
- 2023-05-11
- Completion:
- 2025-05-10
Conditions
- Intrahepatic Cholangiocarcinoma
Interventions
- DRUG
No Results Yet